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Which factors actually influence the development and progression 
of overt nephropathy in Nigerian diabetics?
*A IBRAHIM, **FA AROGUNDADE, **AA SANUSI, ***R IKEM/AO AKINTOMIDE, **AA AKINSOLA 
Abstract
Objective: To determ ine the risk  factors predisposing N igerian  diabetics to overt nephropathy w ith a v iew  to 
developing strategies for its prevention.
Design: case control study.
Setting: Tertiary care hospital, a m ajor nephrology referral centre in N igeria.
Subjects: 30 diabetic nephropathy (D N ) patients and 32 age and sex-m atched diabetic patients w ithout 
nephropathy.
Materials and Methods: 30 diabetic nephropathy (D N ) patients w ith chronic renal failure w ho have been 
diabetic for a m inim um  o f  five years and satisfied the inclusion criteria for the study w ere com pared w ith 32 
age and sex-m atched diabetic patients w ithout nephropathy. Their socio-dem ographic param eters, clinical 
and laboratory profiles w ere determ ined and com pared. R esults w ere analysed using the statistical package 
for social sciences version 10. C hi-square test, logistic regression analysis and Spearm an's rank correlation 
coefficient w ere used, p-value<0.05 was considered as significant.
Main Outcome Measures: The study sought to com pare socio-dem ographic, clinical and biochem ical data 
betw een diabetic patients w ith overt nephropathy and those w ithout.
Results: D uration o f  diabetes, b lood pressures and  b lood  sugar levels w ere significantly  h igher in DN 
patients than the controls (p<0.05). A  fam ily history  o f  renal disease, socio-econom ic status, cigarette 
sm oking, body  m ass index and total serum  cholesterol did not d istinguish betw een D N  patients from  controls 
(p>0.05). Systolic b lood  pressure positively  correlated  w ith serum  creatinine (r=0.057, p<0.001) and 
duration o f  DM  (r=0.284, p=0.02). There w as a constellation o f  clinical features viz: retinopathy, peripheral 
neuropathy and left ventricular hypertrophy, w hich  w ere significantly  associated w ith  D N  (p<0.05). 
Conclusions: Prolonged duration o f  diabetes, hypertension, retinopathy, and peripheral neuropathy, left 
ventricular hypertrophy and poor glycaem ic control w ere the m ajor risk  factors for overt nephropathy am ong 
N igerian  diabetics. A preven tive strategy should include adequate b lood  pressure and glycaem ic control.
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Introduction
Diabetes mellitus (DM) is the commonest endocrine 
disease in the world, with a worldwide prevalence of 
4% in adults.1 In Nigeria the prevalence o f DM ranges 
from 2.4 to 6% and varies from relatively rural to urban 
communities.2 One o f the most serious complications 
o f DM is diabetic nephropathy (DN) with a prevalence 
o f about 4Q%.3 Unlike the previous reports which 
documented the rarity o f diabetic nephropathy 
amongst Nigerians4'11, it is now.a leading cause o f end 
stage renal disease (ESRD) in the world, as it accounts 
for about half of the total population o f patients 
recruited to renal replacement treatment programmes 
in the western world.12 Even locally, the prevalence of 
DN had increased significantly in the last 15 years from 
almost 0% of the causes of chronic renal failure to the 
third commonest cause accounting for 3 to 5% of the 
causes o f ESRD.3,13
Diabetic ESRD causes severe morbidity and high 
mortality and the management is cost-intensive.14 DN 
progresses through five recognised phases, which 
include the stage o f hyperfiltration, during which the 
kidneys hypertrophy and the glomerular filtration rate 
(GFR) increases significantly with a resultant 
relatively low serum creatinine. During the next stage, 
described as the quiescent (silent) phase, the GFR and 
serum creatinine normalises. The third stage is that of 
microalbuminuria or incipient nephropathy stage 
during which spillage o f microalbumin in urine occurs 
and is followed by the overt nephropathy stage during 
w hich m acroalbum inuria  occurs, along with 
developm ent o f hypertension and progressive 
diminution in GFR with a concomitant increase in 
serum creatinine. The last and final stage is end stage 
renal disease during which the patients are overtly 
uraemic and need renal replacement therapy for their 
survival. While the transition from one stage to the 
other could be discerned in type I diabetics, its rather 
blurred in type II disease which is the commonest type 
found in our environment. The implication o f this is 
that the majority o f our diabetics, particularly type II, 
could actually have progressed to incipient or overt 
nephropathy even before or at presentation. This was 
the findings o f both Ikem, et a /15 and Alebiosu, et al16 in 
south western Nigeria.
Diabetic nephropathy, once established, almost 
always progresses to end-stage renal disease (ESRD). 
Fortunately, not all diabetic patients develop 
nephropathy. Indeed, a subset o f diabetic patients 
appears less prone to nephropathy despite long years of 
d iabetes, suggesting  the ex istence  o f  some 
predisposing factors, which are either inherent or 
acquired.16'21
A number of factors have been identified among 
diabetic patient populations that induce and promote 
the development of nephropathy. While some are not 
modifiable, quite a lot o f them can be controlled, 
managed or modified to reduce the progression of the
disease. These non modifiable ones include genetic 
and/or familial predisposition, race, gender, ageing and 
age o f onset as well as duration o f DM.17'21
Genetic factors have, for a long time, been recognised 
as predisposing to nephropathy. There is familial 
clustering o f nephropathy in diabetic siblings. While 
DN was present in 83% of probands with nephropathy, 
it was only 17% in probands without nephropathy. 
Amongst Pima Indians with diabetes, the incidence of 
proteinuria was 14%, if  neither parent had proteinuria; 
23% if one diabetic parent had proteinuria and 46% if 
both parents had proteinuria. Angiotensin gene 
polymorphism is also recognised as influencing a 
predisposition to nephropathy with subjects having DD 
phenotype being worst hit.17 20
Racial predilection is also recognised as predisposing 
to nephropathy. While there is a six fold increase in risk 
o f ESRD in Mexican Americans and American Indians 
compared with whites, the risk is only 2.6 times higher 
in African-Americans when compared with the white 
population.18’21
The duration o f diabetes also influences the evolution 
and progression o f nephropathy. While DN rarely 
develops in the first five years o f diabetes, it is 
uncommon after 15 years. Krowleski, et al. found that 
DN increased rapidly during the second decade o f DM 
and later decreased. Hence the duration o f DM could 
sign ifican tly  im pact on the developm ent o f  
nephropathy.
The modifiable risk factors include socio-economic 
factors, increased body mass index, cigarette smoking, 
h y p e rte n s io n , p o o r g ly caem ic  co n tro l and  
hyperlipidaemia and/or dyslipidaemia.2127 
Hypertension confers worsening o f prognosis in 
diabetics. It favours rapid evolution and progression o f 
glomerulosclerosis and ESRD in patients with DN. Its 
development contributes to progressive decline o f  the 
glomerular filtration rate, rising serum creatinine and 
worsening o f proteinuria.15,25
The benefits derived from good glycaemic control 
were exemplified by the results o f the dialysis 
complications and control trial (DCCT), which showed 
a 56% reduction in the risk of worsening o f 
m ic ro a lb u m in u ria  and  c lin ic a l a lb u m in u ria  
(progression of nephropathy) and 43% reduced risk o f 
developing microalbuminuria in subjects on intensive 
insulin therapy.26
These recognised risk factors act either singly or in 
concert to induce or promote nephropathy. If  the factors 
predisposing to nephropathy are identified in the 
Nigerian diabetic population, it might be possible to 
develop a preventive strategy that will reduce the 
burden of diabetic ESRD in the country, so as not to 
have an epidemic o f diabetic nephropathy similar to 
that currently being experienced in the west.
We, therefore, conducted this prospective case- 
control study to identify the risk factors predisposing to 
diabetic nephropathy and its progression to ESRD with 
a view to developing strategies for its prevention.
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Materials and Methods
Thirty consecutive DN patients referred to the renal 
unit over a 12 month period (between September 2002 
and August 2003) were recruited according to the 
following inclusion criteria:
1. Verified history of DM of duration > 5 years.
2. Apositive dipstickproteinuria>l+in three early 
morning urine specimens.
3. Serum creatinine concentration > 220pmol/L (2.5 
mg%) and creatinine clearance < 30 ml/min.
4. DM prior to renal disease with no history of renal 
disease preceding DM.
Exclusion criteria were: pregnancy, congestive cardiac
failure, evidence of urinary tract infection and 
unwillingness to participate in the study.
Thirty two consecutive DM patients without overt 
nephropathy, who were o f comparable age and sex 
distribution to those with DN were selected from the 
prevalent diabetic patients that were attending the 
endocrine clinic of the hospital according to the 
following inclusion criteria:
1. Verified history of DM of duration > 5years.
2. Negative dipstick proteinuria in 3 early morning 
urine samples.
3. Serum creatinine <132 mmol/1 and creatinine 
Clearance >88 ml/min.
Exclusion criteria were: pregnancy, and refusal of 
consent.
Table I:Socio-demographic and clinical profiles o f patients and controls.
Parameters Patients Controls p value
Mean age (years) 43.36+7.10 41.53+4.18 NS
M :F ratio 1.71 1.28 NS
DM duration (years 12.56+4.29 9.93+3.29 0.009
Type 2 DM 22 (74% ) 2 9 (9 0 % ) NS
% Educated 22 (73.3% ) 27  (85% ) NS
% Sm okers 3 (13.3% ) 1 (3.1% ) NS
BMI 23.91+3.21 23.37+3.2 NS
% with FHRD 2 (6.7% ) 3 (9 .4 % ) NS
% with Neuropathy 26 (86.7% ) 1 5(46 .9% ) NS
SBP (m mHg) 167.86+9.73 136.75+12.29 <0.001
DBP (mmHg) 91.33+13.12 83.65+11.0 0.016
% LVH 2 6(8 6 .7 ) 1 5 (46 .9% ) <0.001
T-cholesterol (mmol/l) 5 .06+0.65 4.90+0.63 NS
FBS (mmol/l) 8 .55+4.45 6.70+1.78 0.01
2 h r PP G lucose (m m ol/l) 10.14+3.41 8.32+1.93 0.01
SeCr (mmol/l) 777.3+32 100.93+20.0 <0.001
FHRD =  Family history of renal disease; SeCr = Serum creatinine
The following parameters were studied: age at DM 
onset, gender, socio-economic status, duration of DM, 
and family history o f renal disease, smoking status, 
body mass index, blood pressure, level of glycaemic 
control, serum total cholesterol, presence o f co­
morbidity (retinopathy, peripheral neuropathy and left 
ventricular hypertrophy).
A detailed history was obtained from each patient 
noting occupation and level o f educational, age when 
diabetes was first diagnosed, history of cigarette 
smoking, family history o f diabetes, renal disease and 
hypertension, and the antidiabetic and antihypertensive 
medications administered. A history o f treatment with 
ang io tensin -converting  enzym e inh ib ito r was 
particularly sought.
A comprehensive general physical examination was 
carried out paying particular attention to the 
cardiovascular system, the nervous system, and the 
eyes.
Body weight was measured in kilogrammes with the 
patient in his or her light clothing using a standing or 
sitting scale. Heights were measured in metres with a 
standard ruler. Body mass index (BMI) was calculated 
from body weight (BW) and height measurements 
using the formula: BMI (Kg/m2) = BW (kg)/Height x 
Height (m2).
Retinopathy was assessed through an ophthalmologic 
examination using a Keeler's ophthalmoscope, with the 
pupils fully dilated.
Diabetic retinopathy28 was classified as:
1. Background or nonproliferative retinopathy if 
there was evidence o f microaneurysm, dot and 
blot haemorrhages or hard exudates.
2. Proliferative retinopathy, if  there was evidence of 
neovascularisation, vitreal detachment, and retinal 
Haemorrhages.
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The presence or absence o f cataract was also noted. 
Hypertensive retinopathy was classified using the 
Keith-Wagener-Baker classification.29 Nervous system 
examination included a full assessment o f the cranial 
nerves, the reflexes and an evaluation for sensory or 
motor impairment.
Blood pressure was measured in the supine and 
s t a n d i n g  p o s i t i o n s  u s i n g  a m e r c u r y  
sphygmomanometer with a standard adult cuff (12cm 
x25cm) applied firmly on the left arm. Measurements 
were taken after the patient had sat comfortably for 
about five minutes. Patients with blood pressure 
persistently higher than 140/90 mm Hg on three 
consecutive clinical readings or patients currently on 
anti-hypertensive m edication w ere considered 
hypertensive.
Left ventricular hypertrophy was determined 
clinically by the position o f the cardiac apex on 
precordial examination, and by electrocardiography, 
using the Sokolow-Lyon criteria (RV5 orV6 SV, orV2 —  3 5  
mm).30
Peripheral neuropathy was determined by impairment 
o f pinprick and joint position sensation at the dorsum o f 
the great toe, and vibration sense using a 128-Hz tuning 
fork.
After careful instructions, a 24 hour urine specimen 
collection was obtained from all patients and controls. 
Midstream, clean-catch urine culture was also done to 
rule out the presence o f urinary tract infection. Patients 
with urine white blood cells o f more than five per ml 
were treated and excluded from the study.
Fresh urine obtained from each patient on at least 
three occasions was used for dipstick protein 
examination (Albustix test) and the results recorded. 
Urinary and serum creatinine concentrations were
measured colorimetrically using the alkaline picrate 
method (Jaffe reaction). This technique measures 'total 
creatinine' which includes non-creatinine chromogens 
in the serum.
Creatinine clearance was calculated using standard 
formula. Blood glucose and serum cholesterol 
concentration were also determined using standard 
methods.
Statistical Analysis.
The sample size (n) will be determined using the 
formula:-
n =(1.96)2 x P (I-  P)
~ 1 T ~
P =Prevalence rate o f  DM in Nigeria is 
2.4% and only about 50% will develop 
nephropathy hence P=1.2% 2. 
d =Tolerable sampling error (0.05)
Hence calculated sample size = 1 8  though 30 
subjects were studied.
The Statistical Package for Social Sciences version 10 
computer programme was used for the analysis. 
Results were expressed as absolute numbers, 
percentages, means with standard deviations, and 
range as appropriate. Chi-square and Fishers exact tests 
were used as appropriate to test significance o f the 
difference o f parameters between the groups. Logistic 
regression analysis was used to identify the risk factors. 
Spearman's rank correlation coefficient was used to test 
the association of some o f the parameters with each 
other. A p value of <0.05 was considered as significant.
Table II: Logistic regression analysis for the risk factors for development o f nephropathy.
Risk factors Odds ratio 95% Confidence 
Interval
p value
Duration o f DM 6.783 -0.346 - -0.074 0.009
Systo lic B lood Pressure 32.723 -0.217 - -0.086 0.0001
D iastolic B lood Pressure 13.736 -0 .209 - -0.094 0.0001
Fasting B lood Sugar 6.609 0.103 - 2.137 0.010
2hr-PP  Blood Sugar 6.296 0.114 - 2.136 0.012
Diabetic retinopathy 17.78 -0.264 - -0.069 0.003
Peripheral neuropathy 10.946 0.109 - 2.142 0.01
Left ventricu lar hypertrophy 16.742 -0.198 - -0.024 0.009
BMI 0.496 -0.172 - 0.428 0.481
Total serum  cholestero l 1.054 -0.41 - 0.20 0.305
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Results
There were 30 DN subjects (18 males and 12 females) 
aged 20 to 57 years (mean 42.36 ±7.1), and 32 controls 
(17 males and 15 females) aged 35 to 52 years (mean 
41.53 ± 4.1). Duration o f DM ranged from five to 21 
years (mean 12.5 ± 4.2) in studied subjects and six to 21 
years (mean 9.9 + 3.2) in controls. Twenty two (74%) 
DN subjects had type II DM while that for the controls 
was 29 (90%) (p>0.05). Twenty two (73.3%) studied 
subjects and 27 (85%) controls had attained only 
primary a level o f education (p>0.05). Trading was the 
most frequent occupation occurring in a similar 
proportion (25%) in studied subjects and controls 
(p=0.57). Apositive family history of renal disease was 
obtained in three (9.4%) controls and two (6.7%) o f the 
studied subjects (p>0.05). A history o f cigarette 
smoking was strikingly low; it was positive in three 
(13%) of the studied subjects and in only one (3%) 
control (p=0.14). BMI ranged from 19 to 31 Kg/m2 
(mean 23. 91 ±3.21) and 18 to 31 (mean 23.34 ±3.23) 
in studied subjects and controls respectively (p>0.05). 
The blood pressure levels exhibited significant 
differences, with SBP ranging from 128 to 192 mm Hg 
(mean 167.86±9.73)in  studied subjects and 110 to 160 
mm Hg (mean 136.75 ±  12.29) in controls (p<0.001). 
Also, DBP ranged between 70 to 130 mm Hg (mean 
96.96 ± 14.24) in studied subjects and 60 to 105 mm Hg 
(mean 83.65 ± 11.00) in controls (p=0.01). While 
diabetic retinopathy was present in 22 (80.9%) o f the 
studied subjects, it occurred only in seven (25.6%) 
controls (p=0.001). Hypertensive retinopathy o f grade 
two to three by Keith-Wagner-Baker classification was 
present in 21 (70%) of the studied subjects and in 13 
(40%) controls (p=0.01). Peripheral neuropathy was 
present in 26 (86.7%) patients and 15 (46.9% controls 
(p=0.001). FBS ranged from 4.1 to 19.1 mmol/1 (mean 
8.55 ±  4.1) in studied subjects and 3.8 to 12.6 mmol/1 
(mean 6 .7+1.78) in controls (p=0.01). Two hour post­
prandial blood sugar (2h-PPBS) ranged from 5.8-20.5 
mmol/1 (mean 10.14 + 3.41) in studied subjects and six 
to 15mmol (mean 8.32 ±  1.93) in controls (p=0.01). 
Total serum cholesterol levels did not differ 
significantly between studied subjects and controls; the 
mean levels being 5.06 ±  0.65 mmol/1 and 4.90 ±  0.53 
mmol/1 in studied subjects and controls respectively 
(p=0.21). Serum creatinine ranged from 252 to 1603 
□ mol/1 (mean 773.3 ±  320) in studied subjects and 60 
to 131 Jmol/1 (mean 100.93 ±  20.0) in controls. 
Creatinine clearance ranged from three to 34 ml/min 
(mean 13.52 + 9.73) in studied subjects and 88 to 102 
ml/min (mean 94.34 ±  12.06) in controls. LVH was 
present in 26 (86.7%) subjects and 15 (46.9%) controls 
(p<0.001). SBP was positively correlated with serum 
creatinine (r=0.057, p<0.001) (Figure I) and duration 
of DM (r=0.284, p=0.02) (Figure II).
Figure I: The relationship between SBP and duration 
o f DM. R=0.284;p=0.025
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Discussion
Diabetic nephropathy is a leading cause o f end stage 
renal disease worldwide and accounts for more than 
50% o f patients on renal replacement therapy 
programmes."223 The mean age o f onset o f DM found 
in our study was consistent with the findings by various 
workers who indicated that type II DM is the 
predominant form o f the disease in this population.21518
In agreement with the suggestions o f Locatelli and 
Del Vecchio,22 socio-economic status assessed in this 
study using surrogates such as level o f education and 
occupation, was not found to be predictive of 
nephropathy. This may have been due to the 
permeating nature o f poverty in the semi-urban 
population o f the study. It is, therefore, not surprising 
that body mass index was not found to be different 
between our patients with DN and those without. This 
was earlier reported by Ikem, et al.15
Duration o f diabetes mellitus o f at least 12 years was 
shown in this study to portend greater risk for 
development o f DN; the finding is similar to those o f 
others.15'16'22 This may be because the majority o f our 
diabetic population are type II DM patients who 
usually present late and have some evidence of 
n e p h ro p a th y , h y p e r te n s io n  o r som e o th e r
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complications even at presentation.12,21'30'31
Hypertension and poor glycaemic control contributed 
to the development of DN in this study in agreement 
w ith  o th e r re s e a rc h e rs .15'16'22, 24 27 P e rs is te n t 
hyperglycaemia has been recognised as to leading to 
glycation o f tissue proteins, increased oxidative stress 
and renal polyol formation, via the aldose reductase 
pathway, leading to glomerulosclerosis and other 
microvascular complications. Increased systemic and 
intraglomerular pressure and activation o f various 
vasoactive hormone pathways have also been 
implicated in the pathogenesis of diabetic nephropathy. 
Both haemodynamic and metabolic pathways are now 
known to independently activate intracellular second 
messengers such as protein kinase C, MAP kinase, 
nuclear transcription factors (NF-kappa B) and various 
growth factors. This ultimately leads to increased renal 
album in perm eability and extracellular matrix 
a c c u m u la t io n , w ith  r e s u l t in g  p ro te in u r ia ,  
glomerulosclerosis and tubulointerstitial fibrosis.32-34
Cigarette smoking is known to exacerbate renal injury 
in diabetic nephropathy and its cessation in those with 
microalbuminuria ameliorates the progressive renal 
injury.2433 This study did not find cigarette smoking to 
be an important discriminator between our subset of 
DN subjects and diabetics without nephropathy, as 
very insignificant numbers had a history o f smoking, 
and in addition it was occasional in them. This might be 
explained by the cultural characteristics o f the local 
population where smoking is regarded as almost a 
taboo. In contrast, cigarette smoking is a major health 
risk in the western world and contributes significantly 
to progression o f DN.22-2433
It is noteworthy that the mean creatinine clearance in 
the studied population was quite low suggesting an 
early onset of CRF. It has been reported that a sizeable 
number o f patients have complications o f  DM at the 
time o f diagnosis o f DN, such as peripheral neuropathy, 
eye disease and ischaemic heart disease.121516-21 The 
finding o f these complications suggests a common 
pathogenetic mechanism with nephropathy. It is, 
therefore, not surprising that we found diabetic 
retinopathy and peripheral neuropathy in 80.9% and 
86.7% o f  the subjects respectively. In addition, they 
were significantly more common in studied subjects 
than in controls.
Intriguingly, total serum cholesterol levels did not 
differ significantly between patients and controls; 
though the different serum lipid fractions which may 
have revealed any form o f dyslipidaemia were not 
assessed. This is being unravelled by an ongoing study.
The limitations o f this study included its being 
hospital based and the fact that it examined diabetic 
subjects with overt nephropathy, as determined by 
positive urinary dipstick for proteinuria, and compared 
them with those without overt proteinuria. Subjects 
with microalbuminuria who are actually in incipient 
nephropathy may have been included in controls.
In conclusion, the risk factors promoting the 
development of nephropathy in Nigerian diabetics are
similar in many respects to those o f the western world. 
Even though factors such as hypertension, poor 
glycaemic control and long duration o f DM were 
uncovered in this study, others such as cigarette 
smoking and obesity (increased BMI) were not found 
to be discriminant factors. Our preventive strategies 
should include adequate control o f blood pressure, 
maintenance of euglycaemia and strict longitudinal 
follow up of diabetic patients. Early detection and 
treatment of DN and diseases associated with it will 
delay the onset o f ESRD.
References
1. King H, Aubert RE, Herman WH. Global 
burden o f diabetes, 1995-2025: prevalence, 
num erical estim ates, and p ro jec tions. 
Diabetes Care 1998;21(9): 1414-31.
2. National Expert Committee on NCD. Non- 
communicable disease (NCD) in Nigeria. 
Report on a national survey 1997.64-90.
3. A leb iosu  CO , K ad iri S, A kang  EU. 
Pathological study o f diabetic nephropathy 
based on renal biopsy: a prospective study. 
Niger J  Clin Pract 2002; l(5):4-9.
4. Akinsola W, Odesanmi WO, Ogunniyi JO, 
Ladipo GOA. Diseases causing chronic renal 
failure in Nigerians: a prospective study o f 100 
cases. AfrJMed Sci 1989;18:131-5.
5. Greenwood BM, Taylor JR. The complications 
o f diabetes in Nigerians. Trop Geog Med 
1968;20:1-12.
6. Oyediran ABO, Akinkugbe OO. Chronic renal 
failure in N igerians. Trop Geog Med 
1970;22:41-5.
7. Person W, MacDonald FW, Shaper AG. 
Diabetic nephropathy in Uganda. East Afr Med 
J  1986;45:89.
8. Osuntokun BO, Akinkugbe FM, Francis TI, 
Reddy S, Osuntokun 0, Taylor GOL. Diabetes 
mellitus in Nigerians: a study o f 832 patients. 
West Afr JMed 1971:295-312.
9. Ojo OS, Akinsola AA, Nwosu SO, Odesanmi 
WO. The pathological basis o f chronic renal 
failure in Nigerians. An autopsy study. Tropic 
GeogMed 1992;44(l-2):42-6.
10. Smith, Adetuyibi. Diabetes in the Nigerian 
African II. Autopsy studies. Trop Geog Med 
1976;28:159-64.
11. Ojogwu LI. The pathological basis o f end- 
stage renal disease in Nigerians: experience 
fro m  B e n in  C ity . West A fr J  Med 
1990;9(3): 193-6.
12. United States Renal Data System: annual Data 
Report. Patient characteristics at the start of 
ESRD. Data from HCFA medical evidence 
form. Am J  Kidney Dis 1999;34(suppl. 1):S63- 
S73.
13. Arogundade FA, Sanusi AA, Akinsola A
14. Friedlander MA, Hricik DE. Optimising end-
33 Cent Afr JM ed  2009;55 (5/8)
stage renal disease therapy for the patient with 
Diabetes mellitus. Sent Nephrol 1997;17:331- 
45.
15. Ikem RT, A kinola NO, Balogun MO, 
Owhovoriole AE, Akinsola A. What does the 
presence o f hypertension portend in the 
Nigerian with non-insulin dependent Diabetes 
mellitus. WestAfrJMedlOOf20(2): 127-30.
16. Alebiosu CO, Odusan O, Jaiyesimi A. 
Morbidity in relation to stage o f diabetic 
nephropathy in type-2 diabetic patients.
17. Merta M, Reiterova R, Rysava D, Kmentova 
D, Tesar V. Genetics o f diabetic nephropathy. 
Nephrol Dial Transplant 2003; 18 [Suppl 
5]:v24-v25.
18. Pettitt DJ, Saad MF, Bennet PH, et al. Familial 
predisposition to renal disease in two 
generations o f Pima Indians with type 2 (non­
insu lin  dependent) Diabetes mellitus. 
Diabetologia 1990;33:438-43.
19. Kastraba JN, Dorman JS, Orchard TJ, et al. 
Contribution o f diabetes duration before 
puberty to development o f microvascular 
complications in IDDM subjects. Diabetes 
Care 1989;12:686-93.
20. Barnes DJ, Pinto JR, Viberti GC. The patient 
with Diabetes mellitus. In: Davison AM, 
Cameron JS, Grunfeld JP, et al (editors). 
Oxford textbook o f clinical nephrology. 2nd ed. 
1998. Oxford: Oxford University Press, New 
York, Toronto, pp: 723-75.
21. Stephensen J, Fuller JH. Microvascular and 
acute complication in IDDM: the EURODIAB 
IDDM Complications Study. Diabetologia 
1994;37:278-85.
22. Locatelli F, Del Vecchio L . Natural history and 
factors affecting the progression o f human 
renal diseases. In: El Nahas A. M, Harris KPG, 
Anderson S (editors), Mechanisms and clinical 
management of chronic renal failure. Oxford: 
Oxford University Press, 2000:20-79.
23. Qari FA: Profile of diabetic patients with end- 
stage renal failure requiring dialysis treatment 
at the King Abdulaziz University Hospital, 
Jeddah. Saudi J  o f Kidney Dis Transplantation 
2002; 13(2): 199-202.
24. Remuzzi G .. Cigarette smoking and renal 
function impairment. Am J  Kidney Dis 
1999;33:807-13.
25. Rossing P, Hommel E, Smidt UM, Parving H- 
H. Impact o f arterial blood pressure and 
albuminuria on the progression o f diabetic 
nephropathy in IDDM patients. Diabetes 
1993;42:715-9.
26. Diabetes Control and Complications Trial 
(DCCT) Research Group. The effect of 
intensive treatm ent o f diabetes on the 
development and progression o f long-term 
complications in insulin-dependent Diabetes
mellitus. N  Engl J  Med 1993 ;329:977-86.
27. Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, 
Cooper RS. Prevalence o f adult diabetes in 
I b a d a n ,  N i g e r i a .  Eas t  Af r  Med  J  
1997;74(5):299-302.
28. Powers AC. Diabetes mellitus. In Braunwald 
E, Fauci AS, Kasper DL, Hauser SL, Longo 
DL, Jam eson JL, (editors). H arrison's 
principles o f  internal m edicine. USA: 
McGraw Hill, 15th ed. 2001:2109-35.
29. Williams GH. Approach to patient with 
hypertension. In: Braunwald E, Fauci AS, 
Kasper DL, Hauser SL, Longo DL, Jameson 
JL, (editors) Harrison's principles o f internal 
m edicine USA: M cGraw Hill, 15th ed. 
2001:211-4.
30. Sokolow M, Lyon P. The ventricular complex 
in LVH as obtained by unipolar, precordial and 
limb leads 1949. Ann o f Noninvasive 
Electrocardiol2001 ;6:343-68.
31. Arije A, Akinsola W, Ladipo GO. Renal 
function in adult Nigerian diabetics. Trop 
GeogMed 1988;40(4):334-7.
32. Gambara V, Meca G, Remuzzi G, Bertani T. 
Heterogenous nature o f renal lesions in type II 
diabetes. J  Am Soc Nephrol 1993 ;3:1458-66.
33. Chuahirun T, Simoni J, Hudson C, Seipel T, 
Khanna A, Harrist RB, et al. Cigarette 
sm oking exacerbates and its cessation 
ameliorates renal injury in type 2 diabetes. Am 
JMed Sci 2004;327(2):57-67.
34. Cooper ME. Interaction o f metabolic and 
h aem o d y n am ic  fa c to rs  in m ed ia tin g  
e x p e r i m e n t a l  d i a b e t i c  n e p h r o p a t h y .  
Diabetologia 2001 ;44(11): 1957-72.
Cent Afr J  Med 2009;55(5/8) 34
This work is licensed under a 
Creative Commons
Attribution -  Noncommercial - NoDerivs 3.0 License.
To view a copy of the license please see: 
http://creativecommons.org/licenses/by-nc-nd/3.0/
This is a download from the BLDS Digital Library on OpenDocs
http://opendocs.ids.ac.uk/opendocs/
Institute o f 
Development Studies
